Brooksville-based pharmaceutical company MCR American Pharmaceuticals recently celebrated its 21st year in the pharmaceutical business.

Brooksville, Florida — May 24, 2012

MCR American Pharmaceuticals recently reached its 21st year in the pharmaceuticals industry. MCR American Pharmaceuticals is a specialty pharmaceutical company that focuses on the marketing, development, sales and distribution of the highest quality medications.

The Brooksville-based company was founded in 1991 by Jack Reagin in Birmingham, AL and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Daniel Ambrose and was relocated to Brooksville, FL. In 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech.

"MCR American Pharmaceuticals is a cutting-edge pharmaceutical company that works hard at providing stellar service," said David Daniel Ambrose, CEO of MCR American Pharmaceuticals. "The company has accomplished quite a bit over the past 21 years, we are working hard on ensuring a fruitful future."

Today the company continues to examine its services and recently announced its reorganization. Rather than work as a middleman, MCR American Pharmaceuticals will work directly with medical professionals and customers.

David Ambrose explained the recent change will further strengthen the company and better position it for future growth. By MCR American Pharmaceuticals reorganizing and working directly with medical professionals, patients will receive better medication prices.

"Selling products directly to doctors through the new site will ensure our top-line products get into patients' hands quicker, and really help build our brand," David Ambrose.

Most pharmaceutical companies charge hefty prices for their products and offer little personal service, however MCR American Pharmaceuticals explained the company decided to remove its middleman and cater directly to its customers because such an approach can be an effective strategy for end users to save money and receive direct care.

Rather than sell its products through a warehouse and charge more money, MCR American Pharmaceuticals sells its medication products on the company's Web site so medical professionals and customers can directly place their order without paying an additional fee to offset the costs of the middleman.

The company currently manufactures and sells 12 medication products that aim to relieve the common cold, sinusitis, hay fever, and allergic rhinitis. The medications include four product families called Congestinex, Maxifed, Maxiphen and Super-Tuss. The Congestinex product family consists of Congestinex, Congestinex C, Congestinex DM and Congestinex PE. Maxifed consists of Maxifed, Maxifed DMX, Maxifed G, and Maxifed DM. Maxiphen consists of Maxiphen and Maxiphen DM. And lastly, the Super-Tuss product family consists of Super-Tuss PE and Super-Tuss PSE.

Congestinex C medication is an antihistamine, available in grape flavor and is recommended for patients who have post-nasal drip cough. Congestinex C can help calm a runny nose and may stop sneezing. MCR American Pharmaceuticals explains that Congestinex C is different from most cold fighting medications in that it is safe for ages two and older. MCR American Pharmaceuticals designed Congestinex C to suit young children by using lower doses of Chlorpheniramine, and Dextromethorphan.

Congestinex DM was launched several weeks ago and is a antitussive and expectorant that arrives in cherry flavor. The medication treats a dry, irritated cough caused by the flu or common cold. MCR American Pharmaceuticals explains that Congestinex DM is used in the treatment of coughs to help expel exudates and secretions. Congestion DM loosens the mucus in the lungs and releases a low dose narcotic cough suppressant that works directly on the brain to decrease the urge to cough.

The last item in the Congestinex product group is Congestinex PE. MCR American Pharmaceuticals explains the medication is an expectorant, antitussive and decongestant that relieves symptoms due to a common cold, hay fever or other respiratory allergies. MCR American Pharmaceuticals explains the benefits to such medication is the low dose of Dextromethorphan, Guaifenesin, and Phenylepherine. The low dosage of such ingredients ensures the medication is suitable for young ages and is safe to consume.

The next medication group that MCR American Pharmaceuticals manufactures is the Maxiphen product family that includes Maxiphen and Maxiphen DM. MCR American Pharmaceuticals explains that Maxiphen is an expectorant and decongestant that contains Phenylephrine and Guaifenesin. Maxiphen helps patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.

The MCR American Pharmaceuticals Maxiphen DM product is an expectorant, decongestant and suppressant that contains Phenylephrine, Guaifenesin, and Dextromethorphan. Maxiphen DM helps patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.

Another medication group manufactured by MCR American Pharmaceuticals is Maxifed. The Maxifed product family consists of Maxifed, Maxifed DMX, Maxifed G, and Maxifed DM. MCR American Pharmaceuticals explains that all four products are good for the common cold, hay fever, and allergic rhinitis.

Maxifed is a decongestant and expectorant combination that contains Pseudoephedrine and Guaifenesin. Maxifed DMX is a decongestant, expectorant and cough suppressant combination that contains Pseudoephedrine, Guaifenesin, and Dextromethorphan. MCR American Pharmaceuticals recommends Maxifed DMX for those who suffer from post nasal drip cough.

Maxifed G is a decongestant and expectorant combination that contains Pseudoephedrine and Guaifenesin and is recommended in fighting the common cold, sinusitis, hay fever, and allergic rhinitis. The final medication in the Maxifed product family is Maxifed DM, an expectorant, decongestant, and suppressant that contains Pseudoephedrine, Guaifenesin, and Dextromethorphan and is strong enough to cure post nasal drip cough.

Lastly, MCR American Pharmaceuticals manufactured Super-Tuss, a medication group that consists of Super-Tuss PE and Super-Tuss PSE. MCR American Pharmaceuticals explains that Super-Tuss PE comes in an AM dose form and a PM dose form. The AM dose is a cough suppressant, expectorant and nasal decongestant combination that contains Dextromethorphan, Guaifenesin, and Phenylephrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

Super-Tuss PSE also arrives in an AM and PM dose form. The AM dose is a cough suppressant, expectorant, and decongestant combination that contains Dextromethorphan, Guaifenesin, and Pseudoephedrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

"MCR American Pharmaceuticals is dedicated to providing individuals with self medication products for in home treatment and prevention of medical conditions and ailments," said David Ambrose.

More About MCR American Pharmaceuticals

Brooksville-based specialty pharmaceutical company MCR American Pharmaceuticals is focused on the marketing and development of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL. and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose and was relocated to Brooksville, FL. and in 2008 the company was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals' products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

For additional information, interview and image request contact VirtuosOnline.